Skip to content

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Generalized Anxiety Disorder Clinical Trials: An Analysis Regarding Engagement Trends and Participation of Generalized Anxiety Disorder Patients Involved in Clinical Trials

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06254157
Enrollment
500
Registered
2024-02-12
Start date
2025-03-31
Completion date
2027-03-31
Last updated
2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Keywords

generalized anxiety disorder

Brief summary

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial. Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of generalized anxiety disorder * Participant must be 18 years of age or older * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.

Exclusion criteria

* Pregnant or lactating woman * Participant is actively receiving study therapy in another * Inability to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Rate of patients who decide to enroll in a generalized anxiety disorder clinical research.3 months
Number of generalized anxiety disorder study participants who remain in clinical study until completion.12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com4159004227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026